Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Daployd-M Tablet ER

Prescription Icon
Prescription Required

Marketer

B.J.Healthcare

Salt Composition

Dapagliflozin (10mg) + Metformin (500mg)

Overview Daployd-M Tablet ER

Diabetic patients with type 2 mellitus may find relief with the extended-release formulation, DuoControl-XR. This dual-action tablet manages elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular health. DuoControl-XR can be taken with meals, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid potential blood sugar spikes and associated risks like renal impairment and vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Commonly reported side effects include headache, nausea, upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), vomiting, and diarrhea. Hydration is crucial to minimize dehydration. Genital fungal infections are a potential concern; meticulous hygiene is recommended. Prior to initiating DuoControl-XR, disclose any kidney, liver, or urinary tract issues, diuretic use, or pregnancy/breastfeeding status to your doctor. Limit alcohol consumption as it may exacerbate side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Daployd-M Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Daployd-M Tablet ER

Managing type 2 diabetes

Major Benefits of Daployd-M Tablet ER:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Daployd-M Tablet ER with a meal.

Common Side effects of Daployd-M Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Daployd-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Daployd-M Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Daployd-M Tablet ER works:

Daployd-M Extended-Release tablets combine dapagliflozin and metformin, two medications that manage blood sugar levels. Dapagliflozin facilitates glucose excretion via the urine, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action promotes superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Daployd-M Tablet ER is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Daployd-M Tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Daployd-M tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Daployd-M Extended-Release tablets to individuals with impaired renal function. Dosage modification of Daployd-M Extended-Release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Extended-release Daployd-M tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Daployd-M Tablet ER :

Should you forget a Daployd-M Tablet ER dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Daployd-M Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Daployd-M Tablet ER
95
MRP 110
13% off